Institutional Sign In

Go

Podravka

Podravka's Cash & Cash Equivalents rose 32.8% yoy to HRK 293 mil in 2015

By Helgi Library - April 2, 2020

Podravka's total assets reached HRK 4,946 mil at the end of 2015, up 41% compared to the previous year. Current as...

Profit Statement
Balance Sheet
Ratios
Valuation

Get all company financials in excel:

Download Sample   $19.99

Get all company financials in excel:

Download Sample   $19.99

May 2016
Statistical Dossier
Jun 2014
Company Report
Jun 2014
Statistical Dossier

Podravka dd is a Croatia-based food company known for its product Vegeta. The Company is structured in three segments: food, beverages and pharmaceuticals. It's offer includes the production of universal food seasoning products under the Vegeta and Podravka brands, as well as products under such brands as Lino (dehydrated baby food), Dolcela (sweets), Kviki (snacks), Cokolino (chocolate cereals and spread), Studena (spring water), Lero (multivitamin drink), Eva (tinned fish and fish products), Talianetta, Fini-Mini, Lero, Warzywko, Coolinarika and others. Podravka dd also produces and markets fruit and vegetable products, as well as tea and condiments. The Company is based in Koprivnica, Croatia.

Finance

Podravka has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 2.79% a year during that time to total of HRK 457 mil in 2015, or 11.5% of sales. That’s compared to 9.76% average margin seen in last five years.

The company netted HRK 398 mil in 2015 implying ROE of 17.7% and ROCE of 12.3%. Again, the average figures were 7.47% and 4.82%, respectively when looking at the previous 5 years.

Podravka’s net debt amounted to HRK 926 mil at the end of 2015, or 0.337 of equity. When compared to EBITDA, net debt was 2.03x, down when compared to average of 2.90x seen in the last 5 years.

Valuation

Podravka stock traded at HRK 337 per share at the end of 2015 resulting in a market capitalization of USD 281 mil. Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 5.55x and price to earnings (PE) of 4.48x as of 2015.